Day: Mbiomics
Inside Stories
Mbiomics: Therapy revolution from the microbiome
The biotech startup mbiomics aims to revolutionize microbiome-based therapies with a novel TechBio platform. The goal: tailor-made medications with over 100 bacterial strains –…
Deals
Series A: 13 million euros for Mbiomics
The Munich-based biotech company Mbiomics, which develops microbiome-based therapeutics, has secured a Series A round of €13 million. In addition to Bayern Kapital,…
